-+ 0.00%
-+ 0.00%
-+ 0.00%

ABBVIE EXEC SAYS EXPECTS APPROVAL OF SUBCUTANEOUS CROHN'S DISEASE TREATMENT IN Q4 - CONF CALL

Reuters·09/09/2026 14:25:43

Please log in to view news